Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Ambap5429

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 68,483Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enforcement Report - Week of February 5, 2025
    Enforcement Report - Week of February 5, 2025

    05 Feb 2025

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-5-2025-48670.pdf

    FDA
    05 Feb 2025
    Share Share
    Astellas Issues Voluntary Nationwide Recall of Prograf
    Astellas Issues Voluntary Nationwide Recall of Prograf

    24 Dec 2024

    // FDA

    https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/astellas-pharma-us-inc-issues-voluntary-nationwide-recall-one-lot-prografr-05mg-tacrolimus-and-one

    FDA
    24 Dec 2024
    Share Share
    TFF Pharma Reports Positive Outcomes From Tacrolimus Powder Trial
    TFF Pharma Reports Positive Outcomes From Tacrolimus Powder Trial

    06 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/06/2925031/0/en/TFF-Pharmaceuticals-Provides-Continued-Positive-Outcomes-from-Tacrolimus-Inhalation-Powder-TFF-TAC-Phase-2-Trial-for-the-Prevention-of-Lung-Transplant-Rejection.html

    GLOBENEWSWIRE
    06 Aug 2024
    Share Share
    TFF provides regulatory update on Tacrolimus Inhalation Powder (TFF TAC)
    TFF provides regulatory update on Tacrolimus Inhalation Powder (TFF TAC)

    24 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/24/2902869/0/en/TFF-Pharmaceuticals-Provides-Regulatory-Update-on-Tacrolimus-Inhalation-Powder-TFF-TAC-Clinical-Program-for-the-Prevention-of-Lung-Transplant-Rejection.html

    GLOBENEWSWIRE
    24 Jun 2024
    Share Share
    TFF Provides Update On TAC Inhalation Powder Lung Transplant Rejection Trial
    TFF Provides Update On TAC Inhalation Powder Lung Transplant Rejection Trial

    15 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/15/2882269/0/en/TFF-Pharmaceuticals-Provides-Update-on-Tacrolimus-Inhalation-Powder-TFF-TAC-Phase-2-Trial-for-the-Prevention-of-Lung-Transplant-Rejection.html

    GLOBENEWSWIRE
    15 May 2024
    Share Share
    TFF Pharma Ph2 TFF TAC Data for Lung Transplant at ISHLT
    TFF Pharma Ph2 TFF TAC Data for Lung Transplant at ISHLT

    29 Apr 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/04/29/2871365/0/en/TFF-Pharmaceuticals-Makes-Available-Phase-2-Data-from-Tacrolimus-Inhalation-Powder-TFF-TAC-for-the-Prevention-of-Lung-Transplant-Rejection-Presented-at-the-Recent-ISHLT-Annual-Meet.html

    GLOBENEWSWIRE
    29 Apr 2024
    Share Share